{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Normal+Healthy&page=2", "query": { "condition": "Normal Healthy", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Normal+Healthy&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-22T18:49:24.858Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00001303", "title": "Effects of Endotoxin in Normal Human Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy", "Lung Disease", "Sepsis", "Septic Shock" ], "interventions": [ { "name": "Reference Endotoxin", "type": "DRUG" }, { "name": "Inhaled Nitric Oxide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institutes of Health Clinical Center (CC)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 198, "start_date": "1992-04-06", "completion_date": "2018-05-17", "has_results": false, "last_update_posted_date": "2018-07-05", "last_synced_at": "2026-07-22T18:49:24.858Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001303" }, { "nct_id": "NCT06482541", "title": "Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Androgenetic Alopecia" ], "interventions": [ { "name": "5 billion exosomes and saline solution microneedling", "type": "COMBINATION_PRODUCT" }, { "name": "50 billion exosomes and saline solution microneedling", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Levit Dermatology", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2024-07", "completion_date": "2025-08", "has_results": false, "last_update_posted_date": "2024-07-16", "last_synced_at": "2026-07-22T18:49:24.858Z", "location_count": 1, "location_summary": "Brooklyn, New York", "locations": [ { "city": "Brooklyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06482541" }, { "nct_id": "NCT02271282", "title": "Estradiol-Receptor Blockade in Older Men and Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Normal Healthy Volunteers" ], "interventions": [ { "name": "Toremifene", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "GHRH/Ghrelin combined Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "50 Years to 80 Years" }, "enrollment_count": 40, "start_date": "2014-12", "completion_date": "2016-05", "has_results": false, "last_update_posted_date": "2016-09-14", "last_synced_at": "2026-07-22T18:49:24.858Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02271282" }, { "nct_id": "NCT06689696", "title": "24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Glaucoma", "GLAUCOMA 1, OPEN ANGLE, D (Disorder)", "Ocular Hypertension", "Ocular Hypertension (OH)", "Ocular Hypertension Glaucoma", "IOP", "Intraocular Pressure", "Glaucoma Open-Angle", "Glaucoma and Ocular Hypertension", "Glaucoma Patients and Healthy Controls", "Normal Tension Glaucoma (NTG)" ], "interventions": [ { "name": "miLens system", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Smartlens, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "22 Years to 80 Years" }, "enrollment_count": 86, "start_date": "2025-02-19", "completion_date": "2026-01-06", "has_results": false, "last_update_posted_date": "2026-04-01", "last_synced_at": "2026-07-22T18:49:24.858Z", "location_count": 3, "location_summary": "Fullerton, California • Petaluma, California • Torrance, California", "locations": [ { "city": "Fullerton", "state": "California" }, { "city": "Petaluma", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06689696" }, { "nct_id": "NCT05117294", "title": "A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Renal Impairment", "Healthy Volunteers" ], "interventions": [ { "name": "Bocidelpar", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Global Development, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 13, "start_date": "2021-12-21", "completion_date": "2022-11-22", "has_results": false, "last_update_posted_date": "2024-10-21", "last_synced_at": "2026-07-22T18:49:24.858Z", "location_count": 4, "location_summary": "Anniston, Alabama • Rialto, California • Miami, Florida + 1 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Rialto", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05117294" }, { "nct_id": "NCT01299142", "title": "Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "FGI-101-1A6", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Functional Genetics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 48, "start_date": "2011-01", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2011-02-18", "last_synced_at": "2026-07-22T18:49:24.858Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01299142" }, { "nct_id": "NCT04482270", "title": "A Study to Investigate the Effect of Mild and Moderate Hepatic Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Hepatic Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatic Impairment", "Healthy Volunteers" ], "interventions": [ { "name": "fezolinetant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Global Development, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "FEMALE", "summary": "18 Years to 75 Years · Female only" }, "enrollment_count": 26, "start_date": "2020-09-02", "completion_date": "2021-03-22", "has_results": false, "last_update_posted_date": "2024-10-17", "last_synced_at": "2026-07-22T18:49:24.858Z", "location_count": 4, "location_summary": "Clearwater, Florida • Miami, Florida • Orlando, Florida + 1 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04482270" }, { "nct_id": "NCT03288220", "title": "Influence of Brain Oscillation-Dependent TMS on Motor Function", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy", "Stroke", "Normal Physiology", "Aging" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 114, "start_date": "2018-09-11", "completion_date": "2029-03-31", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-07-22T18:49:24.858Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03288220" }, { "nct_id": "NCT02700776", "title": "1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Phlebotomy - Blood sampling for GP88 at MM", "type": "OTHER" }, { "name": "SOC Tissue biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "64 Years", "sex": "FEMALE", "summary": "40 Years to 64 Years · Female only" }, "enrollment_count": 417, "start_date": "2014-04", "completion_date": "2017-02-27", "has_results": false, "last_update_posted_date": "2019-11-07", "last_synced_at": "2026-07-22T18:49:24.858Z", "location_count": 2, "location_summary": "Baltimore, Maryland • Glen Burnie, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Glen Burnie", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02700776" }, { "nct_id": "NCT06544642", "title": "A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers", "Sjögren's Syndrome" ], "interventions": [ { "name": "ASP5502", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Global Development, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 116, "start_date": "2024-08-21", "completion_date": "2026-03-05", "has_results": false, "last_update_posted_date": "2026-03-25", "last_synced_at": "2026-07-22T18:49:24.858Z", "location_count": 1, "location_summary": "Daytona Beach, Florida", "locations": [ { "city": "Daytona Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06544642" } ] }